Edition:
United States

Xencor Inc (XNCR.OQ)

XNCR.OQ on NASDAQ Stock Exchange Global Market

37.52USD
10 Dec 2018
Change (% chg)

-- (--)
Prev Close
$37.52
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
109,159
52-wk High
$48.31
52-wk Low
$19.93

Chart for

About

Xencor, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing engineered monoclonal antibodies to treat severe and life threatening diseases. It has developed two clinical-stage product candidates, using its Immune Inhibitor Fc platform: XmAb5871, which is in two Phase II trials... (more)

Overall

Beta: 2.15
Market Cap(Mil.): $1,163.30
Shares Outstanding(Mil.): 46.93
Dividend: --
Yield (%): --

Financials

  XNCR.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -0.87 -- --
ROI: -14.67 0.28 15.02
ROE: -15.16 0.94 16.60

Earnings vs. Estimates